These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Group B, type III streptococcal cell wall: composition and structural aspects revealed through endo-N-acetylmuramidase-catalyzed hydrolysis. De Cueninck BJ; Shockman GD; Swenson RM Infect Immun; 1982 Feb; 35(2):572-81. PubMed ID: 7035367 [TBL] [Abstract][Full Text] [Related]
3. Arthropathic properties related to the molecular weight of peptidoglycan-polysaccharide polymers of streptococcal cell walls. Fox A; Brown RR; Anderle SK; Chetty C; Cromartie WJ; Gooder H; Schwab JH Infect Immun; 1982 Mar; 35(3):1003-10. PubMed ID: 7040244 [TBL] [Abstract][Full Text] [Related]
4. Comparison of inflammatory reactions induced by intraarticular injection of bacterial cell wall polymers. Esser RE; Anderle SK; Chetty C; Stimpson SA; Cromartie WJ; Schwab JH Am J Pathol; 1986 Feb; 122(2):323-34. PubMed ID: 3511727 [TBL] [Abstract][Full Text] [Related]
5. Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro. Janusz MJ; Eisenberg RA; Schwab JH Inflammation; 1987 Mar; 11(1):73-85. PubMed ID: 3552978 [TBL] [Abstract][Full Text] [Related]
6. Comparison of in vivo degradation of 125I-labeled peptidoglycan-polysaccharide fragments from group A and group D streptococci. Stimpson SA; Esser RE; Cromartie WJ; Schwab JH Infect Immun; 1986 May; 52(2):390-6. PubMed ID: 3516872 [TBL] [Abstract][Full Text] [Related]
7. Mast cell activation by group A streptococcal polysaccharide in the rat and its role in experimental arthritis. Dalldorf FG; Anderle SK; Brown RR; Schwab JH Am J Pathol; 1988 Aug; 132(2):258-64. PubMed ID: 3041843 [TBL] [Abstract][Full Text] [Related]
8. Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysaccharide fragments. Stimpson SA; Lerch RA; Cleland DR; Yarnall DP; Clark RL; Cromartie WJ; Schwab JH Infect Immun; 1987 Jan; 55(1):16-23. PubMed ID: 3539800 [TBL] [Abstract][Full Text] [Related]
9. In vivo degradation of bacterial cell wall by the muralytic enzyme mutanolysin. Janusz MJ; Esser RE; Schwab JH Infect Immun; 1986 May; 52(2):459-67. PubMed ID: 3516873 [TBL] [Abstract][Full Text] [Related]
10. Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth. Lichtman SN; Okoruwa EE; Keku J; Schwab JH; Sartor RB J Clin Invest; 1992 Oct; 90(4):1313-22. PubMed ID: 1401067 [TBL] [Abstract][Full Text] [Related]
11. Treatment of experimental erosive arthritis in rats by injection of the muralytic enzyme mutanolysin. Janusz MJ; Chetty C; Eisenberg RA; Cromartie WJ; Schwab JH J Exp Med; 1984 Nov; 160(5):1360-74. PubMed ID: 6387033 [TBL] [Abstract][Full Text] [Related]